Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Objective To determine the epidemiological and clinical significance of invasive fungal infections in non-neutropenic patients in intensive care who stay longer than 10 days on the intensive care unit (ICU).Design Prospective epidemiological multicenter study over a period of 11 months, based on strict clinical, bacteriological, serological and histological criteria.Setting Six surgical and two medical ICUs units in five university and two municipal hospitals.Patients 435 non-neutropenic patients from medical and surgical ICUs with an ICU stay of more than 10 days.Measurements and main results A new occurrence of invasive mycosis (3 sepsis/4 peritonitis/1 disseminated candidiasis), corresponding to the protocol conditions with onset after day 10 in the ICU, was detectable in 2.0% (95% confidence interval 0.85 to 3.8%) of the 409 patients who could be assessed. Candida species were identified as an infection-relevant pathogen in all cases. The most important risk factor for the development of an invasive mycosis was the onset of peritonitis by the day 11 in the ICU (odds ratio 11.3; p = 0.003). A fungal colonization was detected in 64% of patients (Candida species 56%, Aspergillus 4%, and other fungi). Six of 8 patients with an invasive mycosis died on the ICU; ICU mortality in patients with fungal colonization was 31% and in noncolonized patients 26%. Serological tests were not helpful clinically. The sensitivity was 88% for the Candida HAT (haemagglutination test) (threshold titer > 1:160), 100% for the Candida IFT (immunofluorescence test) (threshold titer > 1:80), and 50% for the Candida Antigen Test (Candtec Ramco, threshold titer > or = 1:8), and the specificity was 26, 6, and 73%, respectively. The specificity for the Aspergillus HAT (threshold titer > 1:10) was 29%.Conclusions Invasive mycoses are rare in non-neutropenic ICU patients, even after a longer stay in the intensive care unit; fungal colonization, on the other hand, is frequently detectable. The mortality of invasive mycosis--even with systemic antimycotic therapy--was high; the mortality in patients with fungal colonization was not significantly increased compared to that in noncolonized patients. The serological test procedures, Candida HAT, Candida IFT, and the Candida Ramco Antigen Test, had a low specificity and were not helpful in diagnosing relevant invasive mycosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An earlier study by Petri et al. [43] showed that 64% of ICU patients were colonized, and that all infected patients had been previously colonized.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [43]
Citations
Cites
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Sague, C. M. B., Jarvis, W. R., & System, N. N. I. S. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Major trends in the microbial etiology of nosocomial infection
Schaberg, D. R., Culver, D. H., & Gaynes, R. P. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90346-y · Cited by 1,109
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Hospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831 · cited 1×
“Other studies using uni- and multivariate analyses for the risk of invasive mycoses in medical and surgical patients describe different risk factors with varying reference and significance: previous antibiotic treatments, isolation of Candida species in several body regions apart from the blood, duration of mechanical…”
Result(1999) · Burn Care · doi:10.1201/9781498713979-15 · Cited by 819
Fungal infections complicating acute leukemia
Bodey, G. P. (1966) · Journal of Chronic Diseases · doi:10.1016/0021-9681(66)90066-x · Cited by 521
Fungemia in a Cancer Hospital: Changing Frequency, Earlier Onset, and Results of Therapy
Horn, R., Wong, B., Kiehn, T. E., & Armstrong, D. (1985) · Clinical Infectious Diseases · doi:10.1093/clinids/7.5.646 · Cited by 480
Fungemia in the immunocompromised host
Meunier-Carpentier, F., Kiehn, T. E., & Armstrong, D. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90162-5 · Cited by 463
The Compromised Host and Infection. II. Deep Fungal Infection
Hart, P. D., Russell, E., & Remingtont, J. S. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/120.2.169 · Cited by 364
Nosocomial Infection and Fatality in Medical and Surgical Intensive Care Unit Patients
Craven, D. E. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.5.1161 · Cited by 359 · cited 1×
“In clinical investigations, only specific nosocomial clinical entities in connection with fungi in comparable patient groups or single observations in different ICUs have been reported [ 14 , 15, 17].”
BackgroundRisk factors for nosocomial candidemia: A case-control study in adults without leukemia☆
Bross, J., Talbot, G. H., Greg, M., Shelley, H., & Strom, B. L. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90719-5 · Cited by 275 · cited 1×
“Other studies using uni- and multivariate analyses for the risk of invasive mycoses in medical and surgical patients describe different risk factors with varying reference and significance: previous antibiotic treatments, isolation of Candida species in several body regions apart from the blood, duration of mechanical…”
ResultCandida Sepsis: Pathogenesis and Principles of Treatment
STONE, H. H., KOLB, L. D., CURRIE, C. A., GEHEBER, C. E., & CUZZELL, J. Z. (1974) · Annals of Surgery · doi:10.1097/00000658-197405000-00024 · Cited by 226
The Value of Fungal Surveillance Cultures as Predictors of Systemic Fungal Infections
Sandford, G. R., Merz, W. G., Wingard, J. R., Charache, P., & Saral, R. (1980) · Journal of Infectious Diseases · doi:10.1093/infdis/142.4.503 · Cited by 215
Risk Factors for Candidemia in Patients with Acute Lymphocytic Leukemia
Richet, H. M., Andremont, A., Tancrede, C., Pico, J. L., & Jarvis, W. R. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.2.211 · Cited by 184
Klein, J. J., & Watanakunakorn, C. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90073-1 · Cited by 166 · cited 1×
“The fact that positive blood cultures were only found in 50% of the patients with invasive mycosis can be ascribed to the late dissemination or to the known problems of Candida detection in blood cultures [34, 35], since circulating fungus cells are largely caught in the peripheral capillaries [23].”
BackgroundInvasive aspergillosis. Absence of detectable antibody response.
Young, R. C., & Bennett, J. (1971) · PubMed · doi:10.1164/arrd.1971.104.5.710 · Cited by 154 · cited 1×
“Determination of the Aspergillus HAT for diagnosis of an invasive aspergillosis appears to be unimportant in the presence of a low specificity (threshold titers 1:10; specificity 29 %); this agrees with the reports of other investigators [22, 37].”
ResultEffects of gastric alkalization on bacterial colonization in critically ill patients
GARVEY, B. M., McCAMBLEY, J. A., & TUXEN, D. V. (1989) · Critical Care Medicine · doi:10.1097/00003246-198903000-00002 · Cited by 116 · cited 1×
“As the stay in the ICU grows longer, an increase is observed in fungal detection on mucous membranes as well as in the urine and blood [18, 20, 21]; the significance of fungal colonization for the development of a relevant infection and the influence on mortality, however, is still unclear.”
BackgroundMaki, D. G. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.1.30 · Cited by 114 · cited 3×
“Other studies using uni- and multivariate analyses for the risk of invasive mycoses in medical and surgical patients describe different risk factors with varying reference and significance: previous antibiotic treatments, isolation of Candida species in several body regions apart from the blood, duration of mechanical…”
Changing Etiology of Nosocomial Bacteremia and Fungemia and Other Hospital-Acquired Infections
McGowan, J. E. (1985) · Clinical Infectious Diseases · doi:10.1093/clinids/7.supplement_3.s357 · Cited by 113
Nosocomial infections in intensive care units
Daschner, F. D. (1985) · Intensive Care Medicine · doi:10.1007/bf00273537 · Cited by 100
Disseminated candidiasis in the surgical patient.
Gaines, J. D., & Remington, J. S. (1972) · PubMed · Cited by 90
Nosocomial infection among patients in different types of intensive care units at a city hospital
Chandrasekar, P. H., Kruse, J. A., & MATHEWS, M. F. (1986) · Critical Care Medicine · doi:10.1097/00003246-198605000-00017 · Cited by 80
Identification of Procedure-Related Nosocomial Infections in High-Risk Patients
Wenzel, R. P., OSTERMAN, C. A., Donowitz, L. G., Hoyt, J. W., Sande, M. A., Martone, W. J., Peacock, J. E., Levine, J. I., & Miller, G. B. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.4.701 · Cited by 75
Bodey, G. P., & Anaissie, E. J. (1989) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01963770 · Cited by 60
Developments in the serological diagnosis of opportunistic fungal infections
Burnie, J. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/28.suppl_a.23 · Cited by 23 · cited 1×
“Determination of the Aspergillus HAT for diagnosis of an invasive aspergillosis appears to be unimportant in the presence of a low specificity (threshold titers 1:10; specificity 29 %); this agrees with the reports of other investigators [22, 37].”
ResultThe epidemiology of infections in intensive care units
Emmerson, A. M. (1990) · Intensive Care Medicine · doi:10.1007/bf01709700 · Cited by 22 · cited 1×
“In clinical investigations, only specific nosocomial clinical entities in connection with fungi in comparable patient groups or single observations in different ICUs have been reported [14, 15, 17 ].”
BackgroundFüssle, R., Biscoping, J., ZEILER, D., Michaelis, G., & Sziegoleit, A. (1991) · PubMed · Cited by 17
Diagnosis and management of candidiasis in the immunosuppressed host.
Bennett, J. E. (1978) · PubMed · Cited by 12
Pellinen, T. J., Valtonen, V., LUOMANMÄKI, K., Sivonen, K., & Virtanen, K. S. (1983) · PubMed · Cited by 8
Cited by
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
Eggimann, P., Garbino, J., & Pittet, D. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00801-6 · Cited by 900
Invasive aspergillosis in critically ill patients without malignancy
Meersseman, W., Vandecasteele, S. J., Wilmer, A., Verbeken, E., Peetermans, W. E., & Van Wijngaerden, E. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-093oc · Cited by 547
Taccone, F. S., Van den Abeele, A.-M., Bulpa, P., Misset, B., Meersseman, W., Cardoso, T., Paiva, J.-A., Blasco-Navalpotro, M., De Laere, E., Dimopoulos, G., et al. (2015) · Critical Care · doi:10.1186/s13054-014-0722-7 · Cited by 405
“Although IA has been considered a rare condition among critically ill patients [10-12], recent data indicate that it should be reconsidered as an emerging and devastating infectious disease in this population.”
BackgroundThe changing face of epidemiology of invasive fungal disease in Europe
Lass‐Flörl, C. (2009) · Mycoses · doi:10.1111/j.1439-0507.2009.01691.x · Cited by 369
Cornillet, A., Camus, C., Nimubona, S., Gandemer, V., Tattevin, P., Belleguic, C., Chevrier, S., Meunier, C., Lebert, C., Aupee, M., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/505870 · Cited by 361
Metadata
- Authors
- Petri, M. G., König, J., Moecke, H. P., Gramm, H. J., Barkow, H., Kujath, P., Dennhart, R., Schäfer, H., Meyer, N., Kalmar, P., Thülig, P., Müller, J., & Lode, H.
- Affiliations
- Freie Universität Berlin (DE)
- Heidelberg University (DE)
- Asklepios Klinik Altona (DE)
- Universitätsklinikum Würzburg (DE)
- Krankenhaus Nordwest (DE)
- Universitätsklinik Marien Hospital Herne (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- University Hospital Münster (DE)
- University of Freiburg (DE)
- Venue
- Intensive Care Medicine
- Published
- 1997-03-12
- Volume
- 23
- Issue
- 3
- Pages
- 317-325
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2021610658
- Cited by
- 185
- References
- 31
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 4 · 2022: 1 · 2021: 2 · 2019: 4 · 2018: 4 · 2017: 4 · 2016: 3 · 2015: 1 · 2014: 5 · 2013: 2 · 2012: 2
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Intensive Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- invasive mycosis, invasive fungal infections, non-neutropenic patients, intensive care unit, Candida, peritonitis, fungal colonization, risk factors, mortality, serological diagnosis, Aspergillus, sepsis, systemic candidiasis, ICU length of stay, epidemiology, sensitivity and specificity, histopathology, immunofluorescence
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Candidiasis, Female, Germany, Humans, Intensive Care Units, Length of Stay, Male, Middle Aged, Mycoses, Predictive Value of Tests, Prognosis, Prospective Studies, Risk Factors, Chi-Square Distribution, Logistic Models, Hospital Mortality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.